These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1076 related articles for article (PubMed ID: 8512177)

  • 1. Altered calcium signaling and neuronal injury: stroke and Alzheimer's disease as examples.
    Mattson MP; Rydel RE; Lieberburg I; Smith-Swintosky VL
    Ann N Y Acad Sci; 1993 May; 679():1-21. PubMed ID: 8512177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium and neuronal injury in Alzheimer's disease. Contributions of beta-amyloid precursor protein mismetabolism, free radicals, and metabolic compromise.
    Mattson MP
    Ann N Y Acad Sci; 1994 Dec; 747():50-76. PubMed ID: 7847692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamate, beta-amyloid precursor proteins, and calcium mediated neurofibrillary degeneration.
    Smith-Swintosky VL; Mattson MP
    J Neural Transm Suppl; 1994; 44():29-45. PubMed ID: 7897398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease.
    Mattson MP; Barger SW; Cheng B; Lieberburg I; Smith-Swintosky VL; Rydel RE
    Trends Neurosci; 1993 Oct; 16(10):409-14. PubMed ID: 7504356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity.
    Mattson MP; Cheng B; Davis D; Bryant K; Lieberburg I; Rydel RE
    J Neurosci; 1992 Feb; 12(2):376-89. PubMed ID: 1346802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perturbed endoplasmic reticulum function, synaptic apoptosis and the pathogenesis of Alzheimer's disease.
    Mattson MP; Gary DS; Chan SL; Duan W
    Biochem Soc Symp; 2001; (67):151-62. PubMed ID: 11447832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-amyloid, neuronal death and Alzheimer's disease.
    Carter J; Lippa CF
    Curr Mol Med; 2001 Dec; 1(6):733-7. PubMed ID: 11899259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits.
    Mattson MP; Chan SL
    J Mol Neurosci; 2001 Oct; 17(2):205-24. PubMed ID: 11816794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth factors protect neurons against excitotoxic/ischemic damage by stabilizing calcium homeostasis.
    Mattson MP; Cheng B
    Stroke; 1993 Dec; 24(12 Suppl):I136-40; discussion I144-5. PubMed ID: 8249011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degenerative and protective signaling mechanisms in the neurofibrillary pathology of AD.
    Mattson MP
    Neurobiol Aging; 1995; 16(3):447-57; discussion 458-63. PubMed ID: 7566352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of amyloid precursor protein derivatives and oxidative stress on basal forebrain cholinergic systems in Alzheimer's disease.
    Mattson MP; Pedersen WA
    Int J Dev Neurosci; 1998; 16(7-8):737-53. PubMed ID: 10198821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Numb modifies neuronal vulnerability to amyloid beta-peptide in an isoform-specific manner by a mechanism involving altered calcium homeostasis: implications for neuronal death in Alzheimer's disease.
    Chan SL; Pedersen WA; Zhu H; Mattson MP
    Neuromolecular Med; 2002; 1(1):55-67. PubMed ID: 12025816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases.
    Mattson MP; Pedersen WA; Duan W; Culmsee C; Camandola S
    Ann N Y Acad Sci; 1999; 893():154-75. PubMed ID: 10672236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cholinergic system in aging and neuronal degeneration.
    Schliebs R; Arendt T
    Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal and glial calcium signaling in Alzheimer's disease.
    Mattson MP; Chan SL
    Cell Calcium; 2003; 34(4-5):385-97. PubMed ID: 12909083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation.
    Koistinaho M; Kettunen MI; Goldsteins G; Keinänen R; Salminen A; Ort M; Bures J; Liu D; Kauppinen RA; Higgins LS; Koistinaho J
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1610-5. PubMed ID: 11818564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF.
    Mattson MP; Tomaselli KJ; Rydel RE
    Brain Res; 1993 Sep; 621(1):35-49. PubMed ID: 8221072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth factors prevent mitochondrial dysfunction, loss of calcium homeostasis, and cell injury, but not ATP depletion in hippocampal neurons deprived of glucose.
    Mattson MP; Zhang Y; Bose S
    Exp Neurol; 1993 May; 121(1):1-13. PubMed ID: 8495704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NGF and the Amyloid Precursor Protein in Alzheimer's Disease: From Molecular Players to Neuronal Circuits.
    Triaca V; Ruberti F; Canu N
    Adv Exp Med Biol; 2021; 1331():145-165. PubMed ID: 34453297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.